Related Experiment Video
Updated: Aug 9, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
Comparative interactions of organic Ca++ channel antagonists with myocardial Ca++ and K+ channels
Abstract:
Dose-dependent inhibition by three organic calcium channel antagonists, D-600, nisoldipine and diltiazem, of the inward calcium current (iCa) and the delayed, outward potassium current (iK) in single frog atrial cells was examined using a voltage clamp technique. At holding potentials of -60 mV, low concentrations of these antagonists produced considerable inhibition of iCa without significant alterations in iK, suggesting that iK in single frog atrial cells is not a calcium-activated K+ conductance. Higher concentrations of each of these antagonists, however, inhibited iK. The estimated Kd values for inhibition of iCa and iK, respectively, were 3.7 X 10(-7) M and 8.2 X 10(-4) M for D-600, 1.6 X 10(-8) M and 1.6 X 10(-5) M for nisoldipine and 4.4 X 10(-6) M and 3.3 X 10(-4) M for diltiazem. Under these experimental conditions, D-600 and nisoldipine interact more selectively with myocardial Ca++ channels than K+ channels compared to diltiazem, which is less selective. In addition, the inhibition of iK by each of these antagonists was found to exhibit an apparent voltage dependence; block was enhanced at more negative membrane potentials and relieved at more positive membrane potentials. This voltage-dependent block of iK is, therefore, opposite to the voltage-dependent inhibition of iCa produced by these compounds, where block of iCa is accentuated at positive membrane potentials.
Insights
Three calcium channel blockers, D-600, nisoldipine, and diltiazem, inhibit calcium and potassium currents in frog heart cells. Selectivity for calcium channels varies among these drugs.
Area of Science:
- Cardiovascular Physiology
- Pharmacology
Background:
- Calcium channel antagonists are crucial in treating cardiovascular diseases.
- Understanding their effects on different ion channels is vital for drug development.
Purpose of the Study:
- To investigate the dose-dependent effects of D-600, nisoldipine, and diltiazem on calcium (iCa) and potassium (iK) currents in single frog atrial cells.
- To determine the selectivity of these antagonists for cardiac calcium versus potassium channels.
Main Methods:
- Utilized the voltage clamp technique on isolated frog atrial cells.
- Administered varying concentrations of D-600, nisoldipine, and diltiazem.
- Measured inward calcium current (iCa) and delayed, outward potassium current (iK).
Main Results:
- Low concentrations selectively inhibited iCa, suggesting iK is not primarily calcium-activated.
- Higher concentrations inhibited both iCa and iK.
- D-600 and nisoldipine showed greater selectivity for Ca++ channels than diltiazem.
- Potassium current inhibition was voltage-dependent, contrasting with calcium current inhibition.
Conclusions:
- D-600 and nisoldipine are more selective calcium channel blockers than diltiazem in frog atrial cells.
- The study provides insights into the differential effects and voltage-dependent mechanisms of these calcium channel antagonists on cardiac ion currents.
More Related Videos
07:42Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
Published on: October 18, 2018
08:11Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...